New Zealand Alzheimer's drug gets funding

Scientists from Victoria University have received funding for a world-first Alzheimer's drug that could slow or stop memory loss.

New Zealand scientists who think they've found a way to stop or slow the progression of Alzheimer's have been granted funding to develop their drugs.

Teams from Wellington's Victoria University and the UK's University of Liverpool have received $NZ850,000 ($A801,849) to advance the potential treatment they've been working on since 2008.

Their treatment uses the body's natural sugars to control the degradation of the proteins in the brain that cause memory loss.

Pre-clinical testing of the world-first research is expected to take a further two years and, if successful, clinical trials will follow.

"New drugs that can effectively halt or delay the progression of the disease are urgently needed and this funding is invaluable in progressing our world," Professor Peter Tyler said.


Share
1 min read

Published

Source: AAP


Share this with family and friends


Get SBS News daily and direct to your Inbox

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS News
SBS Audio
SBS On Demand

Listen to our podcasts
An overview of the day's top stories from SBS News
Interviews and feature reports from SBS News
Your daily ten minute finance and business news wrap with SBS Finance Editor Ricardo Gonçalves.
A daily five minute news wrap for English learners and people with disability
Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS
SBS World News

SBS World News

Take a global view with Australia's most comprehensive world news service
Watch the latest news videos from Australia and across the world
New Zealand Alzheimer's drug gets funding | SBS News